NGL FINE-CHEM LIMITED Share Price & Technical Analysis
NGLFINE · ₹2,658 (+0.31%)
Healthcare / Drug Manufacturers - General
₹2,658
+0.31%
NGL Fine-Chem Limited develops and manufactures veterinary APIs, human APIs, intermediates, and finished dosage forms in India, Europe, the Asia Pacific, the United States, and internationally. The company offers afoxolaner, amitraz, atovaquone, buparvaquone, butaphosphan, carprofen, clorsulon, closantel base, closantel sodium, decoquinate, diminazene diaceturate, febantel, fenbendazole, fluazuron…
Price chart
Seasonality
Sep has 1 positive and 4 negative years (last 5 years shown)
1% return in Sep, -7% avg return in past 3 year Sep month.
72% return in 2026, 1% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 19% | 33% | -8% | 5% | 26% | 10% | 6% | -20% | 1% | – | – | – | 72% |
| 25 | -9% | -35% | 7% | -3% | 4% | -1% | 19% | 6% | -2% | 6% | -11% | 6% | -13% |
| 24 | -15% | 5% | 2% | 22% | -13% | 3% | 12% | -19% | -6% | -2% | -10% | -1% | -23% |
| 23 | -4% | -14% | -8% | 24% | -1% | 26% | 2% | 14% | -13% | -9% | 10% | 14% | 41% |
| 22 | – | – | – | – | – | – | -6% | -11% | -7% | 10% | 10% | -14% | -19% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Weak
NGL Fine-Chem Limited develops and manufactures veterinary APIs, human APIs, intermediates, and finished dosage forms in India, Europe, the Asia Pacific, the United States, and internationally. The company offers afoxolaner, amitraz, atovaquone, buparvaquone, butaphosphan, carprofen, clorsulon, closantel base, closantel sodium, decoquinate, diminazene diaceturate, febantel, fenbendazole, fluazuron, flumethrin, flunixin meglumine, fluralaner, halquinol, homidium chloride, imidocarb dipropionate, isometamidium chlroide HCl, lotilaner, marbofloxacin, maropitant citrate monohydrate, nitroscanate, nitroxynil, oclacitinib maleate, oxfendazole, parvaquone, permethrin, phenazone, ponazuril, praziquantel, ractopamine HCL, rafoxanide, ricobendazole, r-praziquantel, sarolaner, s-methoprene, toldimfos sodium, toltrazuril, triclabendazole, xylazine base, xylazine HCl, and zilpaterol. It also provides anthelmintics, antiprotozoals, ectoparasiticides, phosphorus supplements, coccidiostats, and non-steroidal anti-inflammatory drugs. In addition, the company offers atovaquone, nitazoxanide, and praziquantel for anti malarial, anti diarrheal, and anthelmintic therapeutic categories. Further, it provides specialty chemicals, such as meglumine, n-ethyl-d-glucamine, n-octyl-d-glucamine, 1,4,7-trimethyl-1,4,7-triazonane, and Mn-MeTACN. It serves companies engages in manufacturing custom pharmaceuticals. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹18.78B
P/E ratio
32.76
52W high
₹3,602
52W low
₹1,271
Volume
9,067
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,649
Coral Laboratories Ltd.
₹622.2
Frequently asked questions
- What is NGL FINE-CHEM LIMITED share price today?
- NGL FINE-CHEM LIMITED (NGLFINE) last traded around ₹2,658 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NGLFINE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NGLFINE. Download the app for real-time alerts.
- How can I analyze NGL FINE-CHEM LIMITED stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.